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Abstract
Most information about the roles of the adenomatous polyposis coli protein (APC) and its binding partner EB1 in mitotic
cells has come from siRNA studies. These suggest functions in chromosomal segregation and spindle positioning whose loss
might contribute to tumourigenesis in cancers initiated by APC mutation. However, siRNA-based approaches have
drawbacks associated with the time taken to achieve significant expression knockdown and the pleiotropic effects of EB1
and APC gene knockdown. Here we describe the effects of microinjecting APC- or EB1- specific monoclonal antibodies and
a dominant-negative EB1 protein fragment into mammalian mitotic cells. The phenotypes observed were consistent with
the roles proposed for EB1 and APC in chromosomal segregation in previous work. However, EB1 antibody injection also
revealed two novel mitotic phenotypes, anaphase-specific cortical blebbing and asymmetric spindle pole movement. The
daughters of microinjected cells displayed inequalities in microtubule content, with the greatest differences seen in the
products of mitoses that showed the severest asymmetry in spindle pole movement. Daughters that inherited the least
mobile pole contained the fewest microtubules, consistent with a role for EB1 in processes that promote equality of astral
microtubule function at both poles in a spindle. We propose that these novel phenotypes represent APC-independent roles
for EB1 in spindle pole function and the regulation of cortical contractility in the later stages of mitosis. Our work confirms
that EB1 and APC have important mitotic roles, the loss of which could contribute to CIN in colorectal tumour cells.
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Introduction
Since it was first linked with colorectal cancer in 1991 [1,2] the
adenomatous polyposis coli protein (APC) has been extensively
investigated. In particular, its role as a tumour suppressor protein
whose loss of function leads to the development of colorectal
cancer has attracted much attention, eventually identifying a
pivotal role for APC in the WNT signalling pathway [3,4].
However, it is now clear that APC is a multifunctional protein with
additional roles to play within cells, for example in cell motility and
mitosis [5,6]. An interaction between APC and one of its binding
partners, EB1, is thought to play a crucial part in these processes.
The microtubule (MT) plus end-binding protein EB1 was first
identified ina yeast-2-hybrid screen forAPCbindingpartners [7].It
is a highly conserved eukaryotic protein best known for its ability to
localise to growing MT plus ends [8,9] and it therefore belongs to a
group of proteins referred to as +TIPS [5,10]. The interaction
between EB1 and APC is modulated by APC phosphorylation
[11,12], though APC can bind directly to MTs independently of
EB1, using a region located around a basic domain at the C-
terminus of the protein [13–16]. The APC mutations typically found
in colorectal cancers result in the loss of both the MT and the EB1
interaction domains of the protein. In addition to the well-
researched APC-EB1 interaction other interactants of EB1 have
beendiscovered inrecent years.Theycanbe divided into twomajor
groups according to their shared structural domains, the cytoskel-
eton-associated protein-glycine-rich (CAP-Gly) domain proteins
which include cytoplasmic linker proteins (CLIPs) and the large
subunitofthedynactin complex (p150Glued) and the SxIP proteins,
which all share a short and conserved motif. Members of this group
of proteins include (apart from APC) the CLIP associated proteins
(CLASPs), the mitotic centromere associated kinesin (MCAK),
TIP150, the microtubule-actin crosslinking factor (MACF), the
stromal interaction molecule 1 (STIM1), p140Cap, Navigators,
melanophillin, RhoGEF2, CDK5RAP2 and DDA3. [17–24].
During mitosis EB1 has also been demonstrated to interact at
the centrosome with the FGFR1 oncogene partner (FOP) in
combination with CAP350 to form a complex essential for MT
anchorage [25].
Much information has been gathered about the roles of APC
and EB1 with regard to their interactions with MTs in interphase
cells [5,6]. Recent studies also imply that the binding of APC to
EB1 relieves a self-inhibitory EB1 configuration, allowing the
localisation of EB1 to MT tips where it promotes plus end growth
by inhibiting MT catastrophe [26]. However, the roles of APC
and EB1 and the potential functional significance of their
interaction in mitotic cells are not fully understood. Nevertheless,
loss of these functions may be of importance in the development
of colorectal cancer. In particular, the concept that APC
mutation contributes to the genetic instability essential for the
progression from benign polyp to aggressive carcinoma is
compelling [27–30]. Aneuploidy in these tumours may be driven
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cancers initiated by APC mutation [31] and may result from
defects in chromosomal segregation during mitosis. In addition,
studies in non-mammalian systems such as Drosophila and yeast
indicate that APC (or putative APC orthologues) and EB1 are
involved in the process of spindle positioning [5]. Interestingly,
recent publications indicate that EB1 may play a bigger role in
cancers than previously believed. Liu et al. [32] concluded that
EB1 could act as an oncogene through its involvement in the
activation of the WNT signalling pathway in head and neck
cancers and Orimo et al. [33] suggested that EB1 might represent
a prognostic biomarker in hepatocellular carcinoma. Most
recently, Dong et al. [34] proposed an oncogenic role for EB1
in breast cancer. In this study a correlation between EB1 levels
and clinicopathological parameters was found. EB1 siRNA in
breast cancer cell lines was characterised by inhibition of cell
proliferation and EB1 overexpression promoted cell proliferation.
Our current understanding of the roles of the two proteins in
mammalian cell mitosis is mainly based on recent siRNA studies.
APC or EB1 knockdown was found to cause an increased
incidence of defects in chromosomal segregation and errors in
processes such as spindle alignment [35–37], but the mechanistic
basis of these observations remains unclear. Furthermore, Rusan
and Peifer [38] have noted that there are discrepancies in the
findings from different groups in siRNA studies, which compli-
cates the interpretation of their results. In addition to the results
from the siRNA studies in mammalian systems various authors
have revealed mitotic roles of APC and EB1 from observations in
Xenopus extracts. Dikovskaya et al. [39] described a role for APC
in centrosomally driven spindle formation, Zhang et al. [40]
revealed an APC/EB1 interaction in association with BubR1
during metaphase chromosome alignment.
In this study we investigated the roles of APC and EB1 in
mitotic mammalian cells using antibody and recombinant protein
microinjection. We reasoned that this approach could comple-
ment previous siRNA studies by allowing the targeting of specific
regions within, or interactions of, these proteins. In addition, this
approach would permit rapid visualisation of phenotypic effects
in injected mitotic cells without the unavoidable time lags
associated with the siRNA methodology or the expression of
dominant-negative mutants, where mitotic phenotypes might
result indirectly from effects initiated in interphase cells. It would
also avoid the problem of identifying controls for the increased
levels of ß-catenin that should result from loss of APC function in
the WNT signalling pathway, an important consideration given
recent observations [41].
This approach has revealed a number of specific and novel
phenotypes, including mitotic stage-specific cortical blebbing and
asymmetric spindle pole movement following injection with EB1
antibody or dominant-negative EB1 protein. The defects identified
in our studies are consistent with important mitotic roles for APC
and EB1, the loss of which could contribute to CIN in colorectal
tumour cells.
Results
Antibody characterisation
The EB1-specific mouse monoclonal antibody 1A11 was
prepared in collaboration with the Cancer Research UK (CRUK)
Research Monoclonal Antibody Service (RMAS). One of the
driving factors behind its production was the observation that most
commercially available anti-EB1 mouse monoclonal antibodies
recognise epitopes near the C-terminus of the protein. Therefore,
to generate a reagent that would recognise an epitope outside of
this region, the immunogen used to produce 1A11 was the EB1
deletion mutant fusion protein GST-EB1-DC1. This protein lacks
the final 50aa in EB1 [17]. Antibody 1A11 was identified using
purified 6his-EB1 [17] in an ELISA screen of hybridoma
supernatants. This antibody is now commercially available
(ref.2164, Cell Signaling Technology, Inc) and was shown to
specifically react with a 30 kDa protein by Western blot.
In addition to the published data to further define the epitope
recognised by 1A11 we performed an immunostaining screen
against a panel of GFP-tagged EB1 deletion mutants (see Table 1
in Askham et al. [17]), and chimeric EB1/EB2 proteins expressed
in transfected cells (Figure 1A). Co-localisation with 1A11 staining
indicated that the epitope fell outside EB1 aa regions 1–113
(deltaC3, no co-localisation) and regions 150–268 (deltaN3), which
was further narrowed down by co-localisation studies with the
EB1/EB2 chimeras. This indicated that the 1A11 epitope was
located in a region encompassed by aa131–168. To investigate the
specificity of this antibody we carried out RNAi experiments.
HeLA cells were used for EB1, EB2 and EB3 knockdown
experiments. Lysates from these were analysed with the EB1
antibody 1A11 and as a control a commercially available EB1
antibody, clone 5 (BD Transduction Laboratories), by Western
blotting. Binding of both EB1 antibodies was greatly reduced in
the lysates from the EB1 knockdowns, but there was strong
binding to EB1 in the lysates from the EB2 and EB3 knockdowns.
Strong EB1 binding was also observed in the untreated lysate or
the negative control lysate (scrambled) when 1A11 was used
(Figure 1B).
Western blot analysis of COS7 cells and the cell line used in this
study, NRK-52E, with 1A11 and clone 5 (not shown) revealed the
presence of endogenous EB1 (Figure 1C, also Figure S1). We next
examined whether the binding of 1A11 to EB1 inhibited its
interactions with some of its known ligands. The acidic tail in EB1 is
known to be important for its interaction with CLIP-170, but is
thought to be a less important factor in the interaction between EB1
and p150Glued [42,43]. In turn, the interaction between EB1 and
Table 1. Mitotic success rates following antibody
microinjection.
Microinjected
antibody
Number of
microinjected cells (n) Mitosis Rate (%)
4 U 16 Failed 25
Completed 75
1A11 19 Failed 41.1
Completed 58.9
ALI 12–28 16 Failed 43.7
Completed 56.3
C-APC 9.9 18 Failed 11.1
Completed 88.9
C-APC 28.9 15 Failed 26.7
Completed 73.3
This table summarises the percentage of microinjected NRK-52E cells that
completed mitosis within 2 h of injection. Although the majority of
microinjected cells completed mitosis successfully, cells microinjected with
1A11 or ALI 12–28 had a slightly lower success rate than cells injected with the
control antibody 4 U or with C-APC 9.9 and C-APC 28.9. However, statistical
analysis indicated that this was not a significant effect. The failed category
includes cell that had started mitosis but did not finish within 2 h of
microinjection and cells that did not progress in mitosis after microinjection.
doi:10.1371/journal.pone.0028884.t001
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PLoS ONE | www.plosone.org 2 December 2011 | Volume 6 | Issue 12 | e28884Figure 1. Functional characterisation of antibodies used in this study. Panel A. The epitope recognised by the EB1-specific monoclonal
antibody 1A11 was mapped by co-immunostaining of COS-7 cells transiently transfected with a GFP-tagged EB1 deletion series (Table 1, [17]) and
EB1/EB2-GFP chimeric proteins using anti-GFP antibodies (green) and the 1A11 antibody (red). DNA was counterstained using DAPI (blue). The
presence of the 1A11 epitope was confirmed by co-localisation of GFP and 1A11 staining. Chimera1 is an EB1/EB2 hybrid protein, while chimera 2 is
an EB2/EB1 hybrid. This analysis indicated that the 1A11 epitope lies between aa131–168. Scale bar=10 mm. Panel B. Specificity of antibody 1A11 is
revealed by RNAi experiments. Binding of EB1 is greatly reduced in lysates after EB1 knockdown (lane 3), but not after EB2 (lane 4) and EB3 (lane 5)
knockdown. Binding to EB1 is also present in the negative control (scrambled RNA, lane 2) and in normal HeLa cell lysates (lane 1). Similar results are
obtained with commercial EB1 antibody clone 5. EB1 knockdown (lane 7) reduced binding of this antibody, whereas knockdown of EB2 (lane 8) or
EB3 (lane 7) or with scrambled oligos (lane 6) did not affect EB1 binding. Panel C. EB1 is recognized in lysates from COS7 and NRK-52E cells by 1A11
after Western blotting. Panel D. Effects of 1A11 binding on EB1 interactions with ligands. GST-EB1 bound to glutathione-agarose beads was pre-
incubated with 1A11 or non-specific IgG (4 U) before being used in pull-downs from cell extracts. Bound proteins in each pull down were revealed by
EB1 and Mammalian Mitosis
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by p150Glued [17,26,44]. A screen against these three proteins
therefore covers the major binding modes currently identified for
EB1 ligands. Finally, we have recently identified an association
between EB1 and the mitotic kinesin MCAK [45]. It is known that
these major interactions occur during interphase and mitosis,
therefore, we wanted to assess the inhibitory effect of 1A11 on EB1
interactions in cell extracts of NRK-E52 cells.We reasoned that any
observed effect of 1A11 on binding patterns could have implications
for any mitotic phenotypes seen in microinjected cells. To assess the
effect of 1A11 on these interactions in NRK-E52 cells we pre-
incubated GST-EB1 on glutathione-agarose beads with saturating
amounts of either 1A11 or the non-specific IgG molecule 4 U. After
washes, the beads were used in precipitations from NRK-52E cell
extracts followed by SDS-PAGE and Western blotting for CLIP-
170, p150Glued and MCAK (Figure 1D). A summary of the
antibody binding site and binding domains of the major EB1
interactants is shown in Figure S2.
Quantitative immunoblotting for full-length APC is difficult, so
we assessed this interaction using extracts from cells transfected
with a plasmid driving the expression of the APC-derived protein
GFP-APC-C3 followed by Western blotting for GFP (Figure 1E).
GFP-APC-C3 includes both the EB1-binding region and the basic
MT-binding region in APC [11]. These experiments indicated
that 1A11 binding inhibited the GST-EB1 interaction with
p150Glued, had no detectable effect on the association with
MCAK and increased the amounts of both CLIP-170 and GFP-
APC-C3 precipitated by the fusion protein. Finally, we noted that
endogenous EB1 was not displaced from MT ends in interphase
cells microinjected with 1A11, suggesting that antibody binding
did not inhibit the EB1 interaction with MTs (Figure 1F). We
therefore conclude that 1A11 is not a function-blocking reagent,
but that it perturbs the normal equilibrium between EB1 and its
various binding partners.
The anti-APC antibodies used in this study were obtained from
the CRUK RMAS hybridoma bank. ALI 12–28 recognises an
epitope at the N-terminus of APC and has been characterised and
used in other studies [46]. Both of the other antibodies used were
raised against an immunogen consisting of a C-terminal APC
fragment fused to MBP. We further defined the epitopes
recognised by these antibodies by immunostainining cells
transfected with a series of APC C-terminal fragments fused to
GFP [11,47]. The epitope recognised by antibody C-APC 28.9
was not present in any of these constructs though it did recognise
full-length GFP-APC (not shown), indicating that although it lies
towards the C-terminus of the protein it must be located upstream
of aa2127. The epitope recognised by C-APC 9.9 was found to lie
in the basic domain of APC, between aa2126–2511. This
suggested that it might influence the APC interaction with MTs
or other proteins that bind near the APC C-terminus.
To investigate this we first examined the APC-EB1 interaction.
Extracts were prepared from cells expressing APC-C3-GFP. These
extracts were incubated with either 4 U or C-APC 9.9 and
precipitations performed with bead-bound GST-EB1. Precipitates
were subjected to SDS-PAGE and examined for the presence of
APC-C3-GFP. This experiment indicated that the binding of C-
APC 9.9 to APC-C3-GFP in cell extracts potently enhanced the
ability of GST-EB1 to precipitate the fusion protein. Therefore,
with respect to EB1 binding C-APC 9.9 is not a function-blocking
antibody but it appears to shift the normal binding equilibrium
between APC and EB1.
Most microinjected cells complete mitosis
Studies on the role of APC and EB1 during mitosis in
mammalian cells have so far relied on siRNA technology
[30,35,36]. Although these are well-executed and informative
studies, the use of siRNA-mediated expression knockdown has a
number of potential drawbacks. First, it is not possible to be
completely confident about the level of knockdown achieved at the
level of an individual cell under direct observation. Second,
knockdown inevitably takes time. This potentially allows cells to
compensate for any progressive loss of function. In addition and of
particular relevance to the present study, phenotypic endpoints
seen in mitotic cells might have been caused by the blockade of
interphase processes rather than the inhibition of truly mitosis-
specific events. Finally, it is difficult to conclusively exclude off-
target effects in siRNA work. We therefore decided to use antibody
microinjection into living NRK-52E cells and time lapse imaging
to study potential roles for APC and EB1 during mitosis. This cell
line maintains a flattened morphology during mitosis, facilitating
microinjection and imaging of the mitotic apparatus and
SDS-PAGE and Western blotting and the effects of antibody pre-incubation compared. Protein levels were quantified using Quantity One and are
shown in histograms after background subtraction, corresponding band patterns are shown above the histograms. 1A11 pre-incubation inhibited the
binding of GST-EB1 to p150Glued, had little detectable effect on the association with MCAK, and promoted the interactions with CLIP-170 and APC-
C3-GFP, an APC C-terminal fragment containing the EB1- and MT-binding regions in APC. Panel E. Effects of the C-APC 9.9 antibody on the EB1
interaction with APC. The anti-APC antibody C-APC9.9 or control IgG 4 U was added to extracts prepared from cells expressing APC-C3-GFP. The
ability of GST-EB1 to precipitate APC-C1-GFP from these extracts was then examined. The binding of C-APC9.9 to its epitope in the MT-binding region
of APC enhanced the interaction between GST-EB1 and APC-C1-GFP. Protein levels were quantified by Quantity One and presented as histograms
after background subtraction, corresponding band patterns are shown above the histogram. Panel F. Endogenous EB1 is not displaced from MT ends
in NRK-52E cells microinjected with 1A11. Immunofluorescence images reveal localization of EB1 at MT ends after cells microinjected with 1A11 were
fixed and stained with the EB1 antibody clone 5. Fluorescently labelled dextran (red; panel b) indicates a successful microinjection. Immunostaining
with clone 5 (green; panel a) reveals EB1 at MT ends. DNA was counterstained using DAPI (blue). Scale bar=10 mM.
doi:10.1371/journal.pone.0028884.g001
Figure 2. Spindle morphology in failed mitoses. Representative
examples of cells which failed to complete mitosis following injection
with either 4 U (panels a–d) or 1A11 (panels e–h). Fluorescently labelled
dextran (red; panels b, d, f and h) indicates a successful microinjection.
Immunostaining with an anti-tubulin antibody (green; panels a, d, e and
h) reveals that these cells do not contain a properly organised mitotic
spindle. Condensed DNA is revealed by the addition of DAPI (blue;
panels c, d and g, h) Panels d and h show the merged images. Scale
bar=5 mM.
doi:10.1371/journal.pone.0028884.g002
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prophase cells were identified and injected before nuclear envelope
breakdown (NEB).
The four specific monoclonal antibodies (one against EB1 and
three against APC) described above and an unrelated control
monoclonal antibody (4 U) were used for microinjection. The
three APC-specific antibodies provide useful coverage of this large
multi-domain protein. Immediately after antibody injection, cells
were continuously monitored for at least 2 h by time-lapse
microscopy. This time limit was chosen to avoid open-ended
experimental durations and because uninjected cells transited
mitosis well within this time (data not shown). First, we established
whether microinjection with control antibody had a detrimental
effect on mitotic cells. The rates of mitotic failure following
microinjection were calculated and expressed as percentages
(Table 1). 75% of the cells microinjected with the control antibody
4 U successfully completed mitosis within 2 h. Similar results were
obtained for cells microinjected with the APC antibodies C-APC
Figure 3. Mitotic progression in microinjected cells. Stills from representative time-lapse movies of mitotic NRK-52E cells microinjected with the
five different monoclonal antibodies used in this study. A: cell microinjected with the non-specific control IgG 4 U. B: cell microinjected with the EB1
specific antibody 1A11. C: cell microinjected with the APC N-terminus specific antibody ALI 12–28, D: cell microinjected with the APC basic domain
specificantibodyC-APC9.9.E:cellmicroinjectedwiththe APCC-terminus specificantibodyC-APC28.9.Scalebar=10 mM.a-gstillsshowdifferentstages
of mitosis, a- prophase, immediately after microinjection, b- prophase, c- metaphase, d- early anaphase, e- telophase, f–h- telophase/cytokinesis. The
arrowsindicatethepositionofthe chromosomes.F.Thetimespentbyinjectedcellsindifferentstagesofmitosisis summarisedinthis graph.Time point
1 (TP1) represents the time taken from nuclear envelope breakdown to anaphase onset. TP2 represents the time taken from anaphase onset to the start
of telophase. TP3 corresponds to the time taken from the start of telophase until the appearance of a phase-dense midbody during cytokinesis. No
significant differences in the duration of these time points was seen in cells injected with the different antibodies until TP3, which cells injected with
1A11 (p,0.05) and ALI 12–28 (p,0.005) took significantly longer to transit. The graph shows the mean time in min +/2 SEM for each condition.
Significant results are indicated with an asterisk. (4 U, n=12; 1A11, n=9; ALI12–28, n=9; C-APC 9.9, n=14; C-APC 28.9, n=11).
doi:10.1371/journal.pone.0028884.g003
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higher rate of failed mitosis in cells microinjected with the EB1
antibody 1A11 (58.9% completed) and the APC antibody ALI 12–
28 (56.3% completed; Table 1), but these increased rates did not
achieve statistical significance. Immunostaining of cells that had
failed mitosis were examined for obvious morphological defects.
Images of injected cells showed that the spindle had not properly
formed, but there were no differences in the appearance of
arrested cells injected with different antibodies (cells injected with
4 U and 1A11 are shown in Figure 2). We therefore cannot
conclude that the higher failed mitosis rate for the cells injected
with 1A11 and ALI 12–28 was due to a specific effect of these
antibodies. We next examined the movies obtained from cells that
completed mitosis to reveal the effects of antibody injection on a
variety of mitotic processes. Figure 3A–3E shows representative
still images from movies of cells microinjected with the five
different antibodies used in this work. Specific mitotic stages are
shown (for full movies see Movies S1, S2, S3, S4, S5).
Microinjection with EB1 or APC-specific antibodies delays
the onset of cytokinesis
It has been reported that siRNA-mediated depletion of APC led
to transient anaphase delay in human cells [36]. We investigated
the effect of injecting APC and EB1 specific antibodies on the
duration of specific mitotic phases by determining the time taken
by microinjected cells to transit defined time points. Time period
(TP) 1 ran from NEB until metaphase congression, TP2 from the
onset of anaphase until the onset of telophase and TP3 from
telophase onset until the appearance of a phase-dense midbody.
Similar to 4 U-injected control cells, none of the cells injected
with specific antibodies spent a prolonged period in TP1 and TP2.
For example, 4 U injected cells spent 39.565.3 min in TP1 while
1A11, ALI 12–28, C-APC 9.9 and C-APC 28.9 injected cells spent
39.467.5, 47.967.9, 41.066.1 and 39.966.0 min respectively in
the same mitotic stage. In TP2 the lengths of time spent were
11.461.0, 960.7, 14.362.0, 15.662.4 and 1261.7 min. Howev-
er, cells microinjected with either 1A11 (16.362.5 min; significant,
p,0.05, t-test) or ALI 12–28 (20.462.5 min; significant, p,0.005,
t-test) spent more time in TP3 than cells microinjected with 4 U
(11.961.0 min), C-APC 9.9 (11.561.1 min) and C-APC 28.9
(9.961.3 min). These results implicate EB1 and APC in late
mitotic events and they are summarised in Figure 3F.
EB1 and APC injected cells possess a subtly disordered
metaphase plate
siRNA experiments had previously shown that APC or EB1
depletion led to metaphase congression defects that included a
disordered metaphase plate [36] and chromosomal misalignment
[35]. We examined whether similar phenotypes were induced in
microinjected cells. Our first observation was that in movies of
control cells it was usually possible to anticipate the onset of
anaphase. As this event approached, oscillations of the metaphase
plate decreased while the plate itself became tightly compacted.
However, in cells injected with all of the specific EB1 and APC
antibodies we were unable to predict the imminent transition into
anaphase. To objectively analyse this effect we measured the
thickness of the metaphase plate across its widest point in the final
frame before chromosomal segregation was initiated (Figure 4A).
We determined that EB1 and APC antibody microinjected cells
possessed a metaphase plate that was significantly wider than that
present in 4 U injected cells. The average metaphase plate in 4 U
microinjected cells was 5.460.3 mm in comparison to 7.4 mm60.4
in 1A11 injected cells (significant, p,0.005, t-test), 7.2 mm60.4 in
ALI 12–28 injected cells (significant, p,0.005, t-test), 6.6 mm60.5
in C-APC 9.9 injected cells (significant, p,0.05, t-test) and
7.6 mm60.6 in C-APC 28.9 injected cells (significant, p,0.005, t-
test) (Figure 4B). Metaphase plates in cells injected with EB1 and
APC-specific antibodies were otherwise normal in terms of gross
morphology, with no increased incidence of lagging chromosomes,
no evidence of chromosomal decondensation and no other obvious
defects during prometaphase seen in our dataset. Taken in
conjunction with our observation that no increase in the duration
of metaphase was seen in injected cells (Figure 3F), we suggest that
our observations are in general agreement with that of previous
siRNA studies, confirming by a different methodology that
perturbation of EB1 or APC function in metaphase cells causes a
subtle disorganisation in chromosomal congression at the meta-
phase plate without preventing the eventual completion of mitosis.
Figure 4. Microinjection with EB1 or APC specific antibodies
affects chromosomal congression at the metaphase plate. A:
Movies of microinjected cells were examined and the last frame before
anaphase onset identified. The distance separating the widest two
points of the metaphase plate was then measured as indicated. In the
representative examples shown it can be seen that the metaphase plate
was more tightly compacted in cells injected with control IgG (panel a)
than in cells microinjected with 1A11 (panel b). Scale bar=5 mM. The
red traces indicate the outline of the metaphase plates. B: Summary of
the metaphase plate thickness data. The metaphase plate was
significantly wider in cells microinjected with APC or EB1 specific
antibodies when compared to cells injected with the non-specific
antibody 4 U. Mean distances +/2 SEM are shown. Significant results
are shown with an asterisk. P values were for 1A11, p,0.005; ALI 12–28,
p,0.005; C-APC 9.9, p,0.05 and C-APC 28, p,0.005. (4 U, n=11; 1A11,
n=14; ALI 12–28, n=11, C-APC 9.9, n=12; C-APC 28.9, n=7).
doi:10.1371/journal.pone.0028884.g004
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PLoS ONE | www.plosone.org 7 December 2011 | Volume 6 | Issue 12 | e28884Figure 5. Effects of antibody injection on mitotic spindle positioning. Following antibody microinjection in prophase, spindle alignment and
placement was assessed. A: Still image of a cell microinjected with 1A11 at metaphase displaying spindle displacement and misalignment, (a) the
black asterix indicates the geometrical centre of the cell and the yellow asterix the centre of the metaphase plate; (b) the white line indicates the
longitudinal axis of the cell and the black line the axis of the spindle. B: Spindle alignment in microinjected cells at TP1 (onset of anaphase) and TP2
(onset of telophase). At TP1 the greatest amount of spindle misalignment was observed among cells microinjected with 1A11 or C-APC 9.9 and these
cells were also less likely to be correctly aligned at TP2. However, these differences did not achieve statistical significance. (4 U, n=14; 1A11, n=13,
ALI 12–28, n=11, C-APC 9.9, n=9, C-APC 28.9, n=11). C: Spindle placement within the mitotic cell at TP1 was unaffected by APC antibody
microinjection, although spindles were displaced further from the geometric centre of the cell in cells injected with the EB1 specific antibody 1A11.
However, this failed to reach statistical significance (p=0.06). Mean spindle displacement +/2 SEM is shown. (4 U, n=11; 1A11, n=14; ALI 12–28,
n=11, C-APC 9.9, n=12; C-APC 28.9, n=7). D: Movie stills taken from a recording of a representative cell microinjected with 1A11 and fixed at
anaphase. Note that at metaphase (51:00 min) the spindle is misplaced and misaligned. Scale bar=10 mm. For movie of these stills see Movie S6. The
red outline shows cell shape, the white line indicates the longitudinal axis of the cell and the black line the axis of the spindle.
doi:10.1371/journal.pone.0028884.g005
Figure 6. EB1 antibody injection induces anaphase-specific cortical blebbing. A: Stills from a recording of a representative cell
microinjected with 1A11, showing the appearance of cortical blebbing during anaphase (arrows). Scale bar=10 mM. B: The percentage of cells
displaying cortical blebbing is first shown as a percentage of the total number of microinjected cells examined (including those that failed to
complete mitosis) and then as a percentage of microinjected cells that successfully completed mitosis. In both cases a significantly higher proportion
of cells microinjected with antibody 1A11 displayed blebbing (p,0.005 and p,0.05). 1A11-induced blebbing was only seen during anaphase
whereas a lower level of blebbing was noted throughout mitosis in cells injected with anti-APC antibodies (see Figure 2 panels D and E for examples
of blebbing in metaphase cells injected with anti-APC antibodies). Blebbing was not observed in mitotic cells injected with the non-specific IgG 4 U
(zero entry in first column). Significant results are indicated by an asterisk. (4 U, n=16 for total number of microinjected cells, n=12 for cells with
completed mitosis; 1A11, n=19 and 11; ALI 12–28 n=16 and 9; C-APC 9.9, n=18 and 16; C-APC 28.9, n=15 and 11).
doi:10.1371/journal.pone.0028884.g006
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misalignment relative to the longest axis of injected cells
Effects on spindle alignment and placement after inhibition of
EB1 and APC expression have been recorded [35,36]. We
therefore examined these events in our injected cells. Spindle
alignment relative to the longest axis of the cell and spindle
placement within the cell were measured as outlined in the
Methods and Materials and examples are shown in Figure 5A.
We first observed that a higher proportion of cells microinjected
with the EB1 antibody 1A11 and the APC antibody C-APC 9.9
were misaligned relative to the longest axis of the cell at the end of
metaphase (Figure 5B), although these figures were not statistically
significant. All misaligned spindles were correctly aligned by the
end of TP2 except for a minority of spindles in 1A11-injected cells
where only 84.6% were correctly aligned and in C-APC 9.9-
injected cells where 93.7% were correctly aligned.
Only 1A11 appeared to have a detectable effect on spindle
placement within the cell with an average distance of 3.6 mm60.7
from the cell centre recorded. In comparison, spindles in cells
injected with control antibody were on average 1.9 mm60.3 from
the cell centre. The greater misplacement seen in 1A11-injected
cells was not significant (p=0.06, t-test) (Figure 5C). However, it
should be noted that cell size effectively places a limit on the
maximum possible distance from the geometrical centre a spindle
can be located, so the mean value obtained for 1A11 injected cells
could be considered to be more significant than indicated by
statistics. For similar reasons, the increase in spindle size relative to
cell size during anaphase meant that the measurement of spindle
placement in the later stages of mitosis was impractical using this
methodology. An example of spindle misalignment relative to the
longest axis of the cell and spindle misplacement can be seen in
Figure 5D, which shows stills of a cell microinjected with 1A11.
Microinjection with anti-EB1 mAb causes mitotic stage-
specific membrane blebbing
During the analysis of the movies of injected cells, blebbing was
observed in some of the cells microinjected with APC and EB1-
specific antibodies (Figure 6A). In contrast, blebbing was not
recorded in uninjected cells or in cells microinjected with 4 U.
66.7% of 1A11 injected cells displayed mitotic blebbing (p,0.05,
Chi-square test), in comparison to 11.1% of ALI 12–28 injected
cells, 18.7% of C-APC 9.9 injected cells and 27.3% of C-APC 28.9
injected cells (Figure 6B). When these cells were more closely
analysed it was found that blebbing in the APC antibody injected
cells typically arose during pro/prometaphase and persisted
throughout mitosis. In contrast, the blebbing in cells injected with
1A11 was initiated at anaphase onset (Figure 6A, table S1). In all
cases the observed blebbing subsided with mitotic exit. To
investigate stage specific blebbing further we co-microinjected
1A11 and ALI 12–28 and recorded mitotic behaviour as before.
Co-microinjection did not change the late mitotic blebbing
observed after 1A11 injection alone (Figure S3C and D) indicating
that EB1 may have a function in late mitosis independent of APC.
However, the early mitotic blebbing observed after microinjection
of ALI 12–28 was suppressed by 1A11 co-microinjection. Our
observations suggest that perturbation of APC and EB1 function
leads to abnormalities in cortical contractility in mitotic cells.
Asymmetry in spindle pole movement in 1A11-
microinjected cells
As part of our characterisation of the phenotype of injected cells
we next examined spindle pole movement (Figure 7A). Movies
were analysed with Tracking software, enabling us to measure
spindle pole movements, using chromosomal movement as an
easily trackable proxy, and express them as velocity values. The
ratio of the velocities obtained for the two spindle poles in each cell
Figure 7. Microinjection of 1A11 induces asymmetric spindle
pole movement. A: Stills (a–f) taken from a recording of a
representative cell microinjected with 1A11. As shown by the tracks,
one set of chromosomes (the black spot closest to the top of the frame)
remains relatively static within the cell during anaphase B and
telophase while the other moves. The black and red tracks indicate
chromosomal movement. Scale bar=10 mM. B: Velocities were ob-
tained for anaphase chromosomal movement in microinjected cells and
used to derive a ratio that reflected any asymmetry in the observed
movements, with values close to 1 representing symmetrical chromo-
somal separation. A plot showing the range of velocity ratios obtained
is shown. Only cells injected with the EB1 specific antibody 1A11
displayed an asymmetry in movement that generated a ratio of less
than 0.5 (column 2). (4 U, n=14; 1A11, n=14; ALI 12–28, n=10, C-APC
9.9, n=12; C-APC 28.9, n=9). Black line indicates mean value.
doi:10.1371/journal.pone.0028884.g007
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PLoS ONE | www.plosone.org 9 December 2011 | Volume 6 | Issue 12 | e28884Figure 8. Asymmetrical microtubule content in daughters of cells injected with 1A11. Microinjected cells were allowed to complete mitosis
then were fixed andimmunostainedto revealtheMTcytoskeleton.A: Imagesobtained from daughter cells after microinjectionofmothers with 4 U and
1A11. Daughters of cells injected with the control antibody 4 U were equally sized and displayed an equal content of microtubules (a–c), whereas the
daughters of 1A11 injected cells exhibited more uneven microtubule contents (d–i) and in some cases were of unequal sizes (d–f). Scale bar=5 mM. B.
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symmetry of pole movement. We were clearly able to observe
chromosomal movements characteristic of anaphase A and B. We
reasoned as the separation of the segregated chromosomes in
anaphase B is known to be directly coupled to spindle pole
movement during this phase of mitosis, that chromosomal
movement is a fair reflector of spindle pole behaviour in this
context. As shown in Figure 7B, chromosomal movement was
more likely to be asymmetrical in cells injected with 1A11. Only
among cells injected with this antibody was a ratio of ,0.5 seen,
indicating a significant difference in the movement of the spindle
poles. This was recorded for 38.5% of the cells injected with 1A11,
but it was not observed for any of the cells microinjected with
either 4 U or any of the APC-specific mAbs. An example of
uneven pole movement is shown in Figure 6A. Since initial
anaphase chromosomal separation appeared to occur normally in
injected cells, these observations are consistent with a role for EB1
in anaphase B spindle pole movement.
To investigate this phenotype further, the daughters of
microinjected cells that had completed mitosis were fixed and
immunostained for tubulin (Figure 8A). The MT content of these
cells was calculated by measuring the fluorescence intensity of this
staining and the two intensity values were compared. 1A11
injected cells were found to produce a higher proportion of
daughter cell pairs with differing MT contents than the daughters
of cells injected with the other antibodies (Figure 8B). It was also
notable from this work that in some cases the induced asymmetry
in pole movement led to the production of daughter cells of
unequal size (Figure 8A, panels d–f). Comparison of immuno-
stained cells with the corresponding time-lapse series indicated that
the fewest MTs were seen in the cells that inherited the spindle
pole that moved least during anaphase. Interestingly, the cells that
had displayed the most asymmetric spindle pole movement also
generated daughter cells with the greatest discrepancy in
microtubule content (Figure 8C).
A further observation from this work was that in 1A11-injected
cells the anaphase spindle poles were typically not in the same
focal plane (Figure 9A). This observation was reproducible in cells
microinjected with 1A11 then fixed and immunostained at
metaphase (Figure 9B), where 70% of cells (n=10) had spindle
poles that were not in the same focal plane. In comparison, when
control NRK-52E cells were fixed and stained, only 4% of
metaphase cells (n=100) showed the same phenomenon. We
conclude from this that EB1 acts in pathways that maintain mitotic
spindle orientation parallel with the substrate in NRK-52E cells,
The fluorescence content of daughter cells immunostained for tubulin was measured and used to derive a ratio that reflected any asymmetry in the MT
content of the cells, with values close to 1 representing essentially equal MT contents. A plot showing the range of ratio values obtained is shown. The
daughters of cells injected with 1A11 were more likely to exhibit asymmetry in MT content than cells injected with other antibodies. (4 U, n=6; 1A11,
n=9; ALI 12–28, n=5; C-APC 9.9, n=6; C-APC 28.9, n=7). C: A plot comparing the spindle pole movement and microtubule intensity ratios obtained for
4 U injectedcells, n=5 and1A11injectedcells,n=8).Mitoses whereseverelyasymmetricalpolemovementwasseen alsogenerateddaughters withthe
most asymmetrical MTcontents, with daughtersinheritingthe least mobilepole containing fewest MTs. Here, the same coloured shape indicates results
for the same cell within either the 4u- microinjected group of cells or the 1A1-microinjected group of cells.
doi:10.1371/journal.pone.0028884.g008
Figure 9. Microinjection of an anti-EB1 antibody induces tilted
spindles. A. Immunostaining images of 4 U microinjected cells (a) and
1A11 (b,c) fixed and stained at anaphase. The images for the 1A11
injected cell had to be taken separately as the spindle poles were not in
the same focal plane. Arrows indicate the two spindle poles, which were
not in the same focal plane. Tubulin in green, combined anti-EB1 and
dextran staining in red, DAPI in blue. Scale bar=5 mM. B. Immuno-
staining image of 1A11 microinjected cells at metaphase. Arrow
indicates a microinjected cell whose spindle poles are not in the same
focal plane, revealing the presence of a spindle tilted in relation to the
substrate. Tubulin in green, injected 1A11 and fluorescent dextran
staining in red, DAPI in blue. Scale bar=10 mM.
doi:10.1371/journal.pone.0028884.g009
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PLoS ONE | www.plosone.org 11 December 2011 | Volume 6 | Issue 12 | e28884Figure 10. Characterisation of antibody 1A11 binding to EB1 in mitotic NRK-52E cells. A. Binding pattern of the EB1 specific antibody
1A11 in mitotic NRK-52E cells. The antibody binds to the spindle poles in fixed and immunostained cells (a–c) and microinjected, fixed and stained
cells (d–f). Tubulin green, EB1 red, DAPI blue. Scale bar=5 mM. B. EB1 staining patterns of spindle poles at prophase appear to be uneven as indicated
by immunofluorescence of fixed and stained NRK-52E cells. EB1 green (panel a), centrin red (panel b), DAPI blue. Scale bar=5 mM. C. EB1 is more
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[48]. This is likely to be a form of spindle misalignment
mechanistically related to deviations in spindle positioning along
the longest axis of dividing cells. Our failure to detect a statistically
significant increase in the latter (Figure 5) may therefore represent
limitations inherent in our experimental system.
Spindle poles are unevenly decorated with EB1 at
prophase
It is known that EB1 localises to centrosomes and spindle poles
and that it is involved in MT nucleation and/or anchoring at these
sites [17,49]. Strong spindle pole labelling was obtained when
NRK-52E cells were fixed and immunostained with 1A11 or when
cells injected with 1A11 were fixed and probed with an anti-mouse
secondary antibody to reveal the binding location of the injected
antibody, indicating that 1A11 binds strongly to EB1 at this site
(Figure 10A). Western blotting of NRK-52E cell extracts
confirmed that this signal was obtained by antibody binding to
endogenous EB1 (Figure 1C). However, our imaging data
suggested that in many injected cells the antibody had an
asymmetric effect on spindle pole function. It has been reported
that EB1 is present at the mother centrosome throughout the cell
cycle but is only recruited to the daughter centrosome during the
process of centrosomal maturation [49], though the precise timing
of this recruitment is unclear. It therefore seemed possible that the
injection of 1A11 into prophase cells might have occurred at a
time when the recruitment of EB1 to the maturing daughter
centrosome was incomplete. To test this we examined whether
EB1 staining was uniform at both spindle poles in fixed and
immunostained prophase, metaphase and anaphase cells. NRK-
52E cells were co-stained with 1A11 and an anti-centrin antibody
for independent identification of spindle pole location (Figure 10B).
Quantitative analysis of fluorescence intensity revealed a subtle
asymmetry in EB1 immunostaining at prophase centrosomes that
became less obvious with progression through to anaphase. A
significant difference was determined between the prophase mean
and anaphase mean ratios of spindle pole staining intensity
(p,0.05, t-test). This was not observed for centrin, but it was also
evident when cells were immunostained with the EB1 antibody
clone 5. Interestingly, treatment with nocodazole largely prevented
this phenomenon while substantially decreasing the overall EB1
labelling at the spindle poles, suggesting that MTs played a role in
the observed asymmetry (Figure 10C). Again, the mean values
obtained for prophase and anaphase were significantly different in
drug-treated cells (p,0.05, t-test).
Microinjection of a dominant-negative EB1 protein
confirms the data obtained by 1A11 injection
Although the experiments utilising the injection of antibody
1A11 were properly controlled and revealed phenotypes not seen
using a non-specific IgG, we wished to further confirm that the
effects seen were specifically caused by perturbation of EB1
function in mitotic cells. We have previously described the
dominant-negative effects of an EB1 C-terminal fragment termed
EB1-C84 when it was expressed as a GFP fusion protein in
transfected cells [17]. We therefore produced a purified recom-
binant form of this protein, GST-EB1-C84, and used both this
reagent and purified GST in a further series of microinjections.
Initially, both proteins were used at a needle concentration of
1 mg/ml. However, although the majority of GST-injected cells
successfully completed mitosis all cells injected with GST-EB1-
C84 (n=10) arrested in mitosis having failed to assemble a spindle
(data not shown). This phenotype is consistent with the complete
inhibition of EB1 function in injected cells, potentially combined
with the dominant-negative functional inhibition of EB1 ligands.
For example, GST-EB1-C84 binding to p150Glued might be
expected to at least block the direct interaction of this protein with
MTs [50] and the consequences of inhibiting dynactin function in
mitotic cells are well documented [51]. This contrasts, of course,
with the more subtle inhibition of normal EB1 activity expected to
occur in 1A11-injected cells. Therefore, in an attempt to achieve a
less severe inhibition of EB1 function using this reagent we
reduced the needle concentrations of the purified proteins to
100 mg/ml. Under these conditions 37.5% of cells with GST-EB1-
C84 successfully completed mitosis (Figure 11A) in comparison to
64.8% of GST only injected cells. Interestingly, GST-EB1-C84
injected cells displayed several phenotypes which mirrored those
observed in EB1 antibody injected cells. For example, a delay at
TP3 (p=0.01, t-test, significant), diffuse metaphase plates
(p,0.001, t-test, significant), a high proportion of misaligned
spindles relative to the longest axis of the cell (66.6%) that had not
aligned by TP2 (12.1%), and severe asymmetric spindle pole
movements were observed (Figure 11B–E). Again, displacement
was not significantly different (Figure 11F). Blebbing was recorded
in all injected cells in comparison to 60% of control injected cells,
although it did not seem to be stage specific (Figure 11G). It is
possible that microinjection of GST only at the concentration we
used induced blebbing as a cellular response to injection with this
particular protein; however, in contrast blebbing was seen in all
the cells microinjected with GST-EB1-C84 suggesting that there is
also association of EB1 with cortical contractility even though we
did not record stage specific blebbing possibly masked by the GST
only induced blebbing. Examples of control and EB1-C84 GST
fusion protein injected cells are shown in Figure 12. Further
investigation could include a tailless version of the EB1-terminus,
as it cannot bind to most of the known partners of EB1 but acts as
a dominant negative on EB1 itself [50].
We conclude from this work that most of the effects seen
following microinjection with 1A11 are directly related to the
perturbation of normal EB1 function in mitotic cells (for full
movie see Movies S7 and S8).
Discussion
In this study we aimed to investigate the roles of APC and EB1
in mitotic mammalian cells by antibody microinjection. Our
antibody characterisation suggested that rather than directly
inhibiting EB1 or APC function the antibodies used induced a
shift in the usual balance of ligand binding, which in turn
influenced EB1 and APC function. Perhaps the most likely
explanation for the EB1 data is that p150Glued appears to be the
most important EB1 ligand within cells, as evidenced by findings
in a previous study where GST-EB1 was used in pull-downs from
extracts of cells containing radiolabelled proteins [52]. The major
precipitated species observed in this experiment were p150Glued
and its binding partner cytoplasmic dynein intermediate chain.
Since we have previously shown that EB1 ligand binding is
competitive [17], a simple interpretation of our findings is that a
reduction in p150Glued binding permits increased interactions
with CLIP-170 and APC, which are key players in MT
interactions and which may have an effect on MT dynamics
unevenly distributed on centrosomes in prophase than in the later stages of mitosis, especially when compared to anaphase, in both the presence
and absence of nocodazole (significant results are indicated with an asterisk, p,0.05).
doi:10.1371/journal.pone.0028884.g010
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interaction with EB1 is instrumental in anchoring newly nucleated
microtubules at centrosomes and perhaps also at the spindle poles
during mitosis [17,53,54]. Reducing p150Glued interactions with
EB1 in the earliest stages of mitosis via antibody blocking might
therefore reduce the efficiency of microtubule anchoring at spindle
poles, potentially explaining the phenotypes observed in our
experiments.
Recent findings on the roles of APC and EB1 in mitosis have
suggested that they act during chromosomal congression and
segregation and are involved in spindle orientation, functions that
are likely to be mediated by their interactions with MTs. We
therefore examined our data for phenotypes associated with these
processes. Our analyses revealed that there were some phenotypes
associated with the injection of both APC and EB1 antibodies,
implying that both proteins act in a common pathway, while some
were specific for the EB1 antibody, suggesting that it has mitotic
roles independent of its interaction with APC. In the first group,
our results confirmed data recently presented by other workers
[35,36]. We found that injection of antibodies against APC and
EB1 induced a less organised metaphase plate without preventing
the eventual completion of mitosis. We also noted effects on the
spindle itself after antibody microinjection. Injection with 1A11
also increased the incidence of spindles that were tilted in relation
to the cell substrate (Figure 9), a phenotype that can be considered
to be a form of spindle misalignment and that again confirms that
an EB1 phenotype first identified by a siRNA approach is
recapitulated by our methodology [48]. However, we were unable
to identify a significant role for EB1 in spindle alignment along the
longest axis of dividing cells, a phenomenon that one would
assume was mechanistically related to our observation of tilted
spindles. This probably represents a consequence of limitations in
our experimental system, most likely related to our small sample
size since a trend of misalignment was seen that failed to reach
significance. We were also unable to confirm that APC plays a role
in spindle alignment or placement in our experimental system.
We were therefore able to induce by microinjection at prophase
a number of phenotypes previously observed by other workers
following the knockdown of EB1 or APC expression. This
indicates that these effects are directly associated with the function
of APC and EB1 during metaphase and that they are not a
consequence of an interphase defect affecting subsequent mitoses,
or a result of cell adaptation in response to a gradual depletion of
protein levels. They also indicate that our experimental approach
is valid and that the injected mAbs are affecting the function of
their targets. In the case of C-APC 9.9, epitope mapping suggests
that this could be due to a direct inhibition of the APC interaction
with MTs. Intriguingly, our data also revealed two striking
phenotypes that were specifically associated with EB1 antibody-
microinjection but had not been reported in previous studies.
These were anaphase-specific cortical blebbing and asymmetric
spindle pole movement.
EB1 antibody injection causes anaphase-specific cortical
blebbing
Movies of microinjected cells revealed that cells injected with
1A11 often displayed cortical blebbing during anaphase. Blebbing
is not uncommon in mitotic cells. However, in our hands cortical
blebbing during mitosis was never seen in either uninjected NRK-
52E cells or cells injected with control IgG. Furthermore, it is
unlikely that the blebbing observed after mAb injection was
associated with apoptotic processes since it did not lead to cell
death and resolved in daughter cells when mitosis was completed.
Blebbing was also seen at a much lower level in cells injected
with the anti-APC mAbs. However, this blebbing was observed
from prophase onwards and did not display any specificity for a
particular mitotic stage. It is known that APC interacts with the
actin cytoskeleton in migrating cells via factors such as the Cdc42-
activating factor Asef and IQGAP1 [55–57] while we have
examined its actin-dependent localisation to adhesive membranes
[46] and noted a cortical localisation in mitotic NRK-52E cells
[58]. It therefore seems possible that the blebbing observed after
microinjection with the APC antibodies may be due to the
disruption of an APC function that impacts upon the actin
cytoskeleton in mitotic cells but is independent of its interaction
with EB1.
The blebbing induced by 1A11 is arguably of greater interest.
Our data suggests that this phenotype is caused by perturbation of
an EB1-specific function in the late mitotic cell that is independent
of its interaction with APC. It is tempting to speculate that this
function is involved in the correct specification of the cleavage
furrow. It is now clear that spindle MTs, in particular astral MTs
and those forming the spindle midzone [59–61], play an important
role in controlling cortical contractility. This is achieved, at least in
part, through the local activation of RhoA. EB1 is known to
interact with the Rho effector mDia [62], while in Drosophila an
interaction with a Rho activating protein (DRhoGEF2) has been
identified [18]. If a similar interaction exists in mammalian cells
EB1 would be well placed to fulfil a role in the MT-dependent
regulation of contractility at the mitotic cell cortex. An alternative
explanation would be that EB1 function is involved in repressing
ectopic cleavage furrows or contributing to cortical relaxation
away from the cleavage furrow. Severe blebbing was observed in
Dictyostelium and Drosophila after loss of the actin nucleation factor
SCAR/WAVE suggesting a role in cell cortex maintenance.
Depletion of EB1 revealed a role in localising SCAR at mitosis as
well as migration [63]. This role appears to be recapitulated in
mouse melanoma cells where EB1-depletion leads to the inhibition
of lamellae formation and migration [64]. However, our previous
work [65] has shown an increase in astral microtubule length and
number in anaphase NRK-52E cells and images of microinjected
anaphase cells stained with another EB1 antibody in this study
clearly show that astral microtubules in microinjected cells still
reach the cell cortex (figure not shown).
To further investigate the blebbing phenomena we co-
microinjected 1A11 with the APC antibody ALI 12–28. The
simplest result to summarise from this work is that ALI 12–28 co-
injection had little effect on the anaphase blebbing caused by 1A11
injection; this supports the contention that this blebbing arises
from the perturbation of an APC-independent function for EB1,
possibly by inhibiting the binding of p150Glued and/or promoting
the interaction of CLIP-170 with EB1. On the other hand, we
observed that co-injection of 1A11 suppressed the prophase-
specific blebbing caused by ALI 12–28 injection. This is a more
difficult result to explain. It seems likely that ALI 12–28 is an APC
Figure 11.Microinjection of an inhibitory EB1 fragment into NRK-52E cells recapitulates phenotypes observed in EB1 antibody injected
cells. Mitotic NRK-52E cells were microinjected withthedominant-negative EB1 fragmentGST-EB1-C84or withGSTalone. A) Injection of low levels ofGST-
EB1-C84 inhibited progression through mitosis. B) Cytokinesis was significantly delayed in mitotic cells injected with GST-EB1-C84 that completedm i t o s i s
(p=0.01). C) Chromosomal congression to the metaphase plate was significantly inhibited in cells microinjected with GST-EB1-C84. D) The majority of cells
microinjected with GST-EB1-C84 had misaligned spindles at TP1, most of which had not corrected by the time cells reached telophase. E) Some cells
microinjectedwithGST-EB1-C84showedsevereasymmetryinspindlemovement,asshownbyaratiovalueof,0.5.Differentcoloursandshapesrepresent
individualcells.(F)CellsinjectedwithGST-EB1-C84tendedtopossessspindlesthat wereplacedfurtherfromthecellcentre,thoughthistrenddidnot reach
statistical significance. (G) A higher proportion of cells injected with GST-EB1-C84 exhibited cortical blebbing, though it was not mitotic stage specific.
doi:10.1371/journal.pone.0028884.g011
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PLoS ONE | www.plosone.org 15 December 2011 | Volume 6 | Issue 12 | e28884Figure 12. Microinjection of mitotic NRK-52E cells with GST or GST-EB1-C84 fusion protein. Stills from representative time-lapse movies
of mitotic NRK-52E cells after microinjection with GST alone (A, a–h) or GST-EB1-C84 (B, a–h). Black arrows indicate the position of the chromosomes.
Note cortical blebbing and the formation of an ectopic cleavage furrow, which is resolved by the time the GST-EB1-C84 injected cell reaches
cytokinesis (B, red arrow) C: The cells shown in A and B were fixed and immunostained with an antibody specific for alpha-tubulin (green) and
counterstained using DAPI (blue). Injected cells were identified by the presence of fluorescent dextran (red). The cells shown in a and b are daughter
cells of the cell injected with GST, while the cells in c and d are daughter cells of the cell injected with GST-EB1-C84. Note the formation of uneven
daughter cells after microinjection with the GST-EB1-C84 protein. Merged images are shown in b and d. Scale bars=10 and 5 mm.
doi:10.1371/journal.pone.0028884.g012
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our antibody characterization work (Figure 1) that 1A11 promotes
the EB1-APC interaction. 1A11 injection does not induce
prophase blebbing, hence promoting the APC-EB1 interaction
does not seem to impact on this APC function. However, our
previous work would imply that 1A11 could have no effect on
APC function at this time point, since the APC-EB1 interaction is
blocked in early mitosis by APC phosphorylation [11]. It therefore
remains unclear how 1A11 suppresses the effects of ALI 12–28
injection. We might speculate that ALI 12–28 effects on APC
include an inhibition of APC mitotic phosphorylation that permits
1A11-promoted EB1 binding that somehow restores APC
prophase function. Alternatively, and perhaps more likely,
suppression of the EB1-p150Glued interaction or promotion of
the EB1-CLIP-170 interaction might antagonize the effects of ALI
12–28 injection via pathways that are independent of APC,
perhaps involving modulation of microtubule dynamics.
In all other parameters examined no additive or suppressive
effects were seen when both 1A11 and ALI 12–28 were co-
injected, suggesting that EB1 and APC act in the same pathway
where these phenomena were seen with injection of each antibody
alone (for example failure to complete mitosis, mitotic timings and
spindle alignment; Figure S3A, B and E) and confirming that the
effect of 1A11 on spindle pole movement was independent of APC
(Figure S3F).
A role for EB1 in spindle pole movement
In a proportion of cells injected with 1A11 the spindle poles
were observed to move asymmetrically, with one pole essentially
immobile in the most extreme examples. An analysis of the MT
content in the two daughter cells of completed mitoses revealed
that cells containing a centrosome derived from the less mobile
pole contained fewer MTs than their siblings. Tellingly, the
greatest discrepancy in MT content was found between cells
produced by mitoses that displayed the most severe spindle pole
movement defect. We have previously shown that a sharp increase
in the length and number of astral MTs at both spindle poles
occurs in anaphase NRK-52E cells and that this is required for
efficient spindle orientation [65]. Spindle pole movement in these
cells is mediated, at least in part, by pulling forces exerted on astral
MTs by dynein/dynactin complexes [66]. In sum, these
observations are consistent with the idea that injection of 1A11
specifically antagonises EB1 function at one spindle pole. As a
consequence, astral MT nucleation and/or growth are impaired
from this pole, preventing linkage between pole and cortex and
denying the possibility of movement generated by MT motors.
These phenomena may be explained by an extension of the known
centrosomal functions of EB1 to mitotic cells [10].
The morphology and life cycle of the centrosome provides clues
that could help clarify our observations [67]. During DNA
replication in S-phase the centrosome duplicates in preparation for
mitosis. A single centrosome consists of two centrioles, with the
older termed the mother and the younger the daughter. The
original centrosome duplicates by a semi-conservative mechanism,
resulting in one new centrosome obtaining the older mother
centriole and the other the daughter. The latter gradually matures
by recruiting proteins that form a pericentriolar matrix that drives
MT nucleation and, after mitosis, acquiring structures termed
subdistal appendages that function in MT anchoring. During the
entry to mitosis both centrosomes undergo a dramatic reorganisa-
tion, recruiting a number of accessory proteins as a result of which
a step-change in MT nucleation capacity is achieved [67]. Could
subtle differences in this process between the two centrosomes
explain the phenotype encountered in 1A11-injected cells?
Louie et al. [49] previously demonstrated that EB1 preferen-
tially localises to the mother centrosome until the approach to
mitosis. We propose that this asymmetrical association of EB1 with
duplicated centrosomes, or the asymmetrical distribution of an
EB1 functional interaction with a centrosomal binding partner
such as p150Glued, could explain our results (Figure 14). In some
early prophase cells functionally active EB1, regulated in an as yet
un-identified way, could be primarily localised to the spindle pole
containing the mother centriole. It seems possible that in some
cells injection might have occurred early enough to block the
Figure 13. Diagram showing the possible interactions of EB1
with main interactants and the effect of antibody binding.
Blocking of EB1 with 1A11 enhances some interactions (CLIP-170, APC),
reduces interactions with p150Glued and has no effect on other
interactions, for example with MCAK (shifted balance after preincuba-
tion with specific antibody).
doi:10.1371/journal.pone.0028884.g013
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subsequently recruited to the younger pole after injection was
unaffected (Figure 14, model A). In this model the mother spindle
pole is functionally impaired. In a more complex model, we can
imagine a situation where at the point of antibody injection EB1 is
already stably associated with a specific binding partner at the
mother centrosome. In contrast, antibody-bound EB1 subsequent-
ly recruited to the daughter centrosome during prophase is unable
to associate with this ligand. This model leads to a deficiency in an
EB1 functional interaction at the daughter spindle pole during
mitosis. In both models, the resulting imbalance in the amount of
functional EB1 at the spindle poles could lead to uneven pole
movement in anaphase by interfering with astral MT nucleation
and growth at one pole in a manner analogous to that previously
described in interphase cells when EB1 function at the centrosome
is perturbed [17,49].
Supporting the initial requirement for both of these hypotheses,
we observed that prophase cells had a more uneven distribution of
EB1 at the spindle poles, an asymmetry that normally disappeared
as mitosis progressed. Furthermore, we identified target cells for
injection on the basis of phase-visible DNA condensation but no
NEB. This technique could not discriminate between cells in the
very early stages of prophase and those where NEB was imminent.
This might explain why only a fraction of microinjected cells
showed severely asymmetrical spindle pole movement, since some
cells may have been injected when EB1 functional recruitment to
the daughter spindle pole was well advanced. It is also worth
noting that this phenotype could easily have been missed in
previous studies using siRNA-dependent knockdown of EB1
expression, since EB1 function at both poles would be likely to
have been lost using this approach.
Further research on this topic will therefore be focused on
investigating the function of EB1 and its potential binding
partners at spindle poles in more detail. Observations from other
experimental systems where EB1 proteins have been implicated
in spindle asymmetries may provide useful cues in this work. For
example, deletion of the fission yeast EB1 orthologue Mal3 in
combination with the deletion of its binding partner Moe1
restricts the localisation of gamma-tubulin to only one spindle
pole body and causes the formation of abnormal spindles [68],
while in dividing S. cerevisiae the EB1 orthologue Bim1p
complexed to Kar9p is initially restricted in its distribution to
the older spindle pole body as part of a process that ensures
proper spindle alignment [69]. Most recently, Fong et al. [70]
demonstrated a direct interaction between EB1 and
CDK5RAP2, a centrosomal protein, which was shown through
its association with EB1 to localise to microtubules at the distal
tips. By suppressing EB1 expression microtubule tip-tracking of
CDK5RAP2 was inhibited leading to altered microtubule
dynamics and stability.
Figure 14. Models for the possible functional effects of antibody 1A11 in microinjected cells. (A) In uninjected cells EB1 (orange triangle)
is initially localised to the mother spindle pole (blue rectangle) and is recruited to the daughter (black rectangle) during prophase, giving both poles
functional equivalency in MT nucleation and/or anchoring during and after mitosis. (B) In microinjected cells the antibody binds preferentially to EB1
located at the mother spindle pole early in prophase and antagonises its function. The function of EB1 newly recruited to the daughter pole is not
affected, leading to proper nucleation and/or anchoring of microtubules at the daughter but not the mother pole. The uneven distribution of
functional EB1 at the poles leads to asymmetries in mitotic pole movement and MT content in daughter cells. (C) EB1 at the mother pole is associated
with a binding partner (green circle) important for its function at this site. Antibody binding does not antagonise the function of pre-existing
complexes, but it inhibits the functional associations of EB1 newly recruited to the daughter pole. This results in normal nucleation and/or anchoring
of microtubules at the mother but not the daughter pole, again leading to asymmetries in mitotic pole movement and MT content in daughter cells.
doi:10.1371/journal.pone.0028884.g014
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microinjection of living mitotic mammalian cells with specific
antibodies to APC or EB1 perturbs functions for these proteins in
chromosomalcongressionandlatemitoticevents.Furthermore,EB1
appears to play a more widespread role in mitosis than previously
revealed by siRNA studies, being involved in late mitotic processes
that impact upon spindle pole movement and the regulation of
cortical contractility. It seems likely that further research into the
mitotic roles of EB1 and APC will lead to a better understanding of
one of the most fundamental processes in cell biology.
Methods
Antibodies
Five monoclonal antibodies (mAbs) were used for microinjection
in this study. These were a non-specific mouse IgG control,
designated 4 U; 1A11, an EB1-specific mAb; C-APC 9.9, a mAb
specific for the APC C-terminus; C-APC 28.9, another mAb
raised against the APC C-terminus; and ALI 12–28, a mAb
specific for the APC N-terminus. All of these antibodies were
obtained as endotoxin-free preparations from the Cancer
Research UK Research Monoclonal Antibody Service at concen-
trations ranging from 0.7–1 mg/ml in PBS. Antibodies used for
immunostaining included a monoclonal rat anti-alpha tubulin
antibody (Serotec), a rabbit polyclonal anti-centrin 1 antibody
(Sigma) and the EB1-specific mAb clone 5 (BD Transduction
Labs). All secondary antibodies were Alexa Fluor-conjugated
reagents obtained from Molecular Probes.
Cell culture
NRK-52E (normal rat kidney epithelial) cells obtained from the
European Culture and Cell Type Collection were cultured as
previously described [65]. Nocodazole treatment was performed
essentially as described previously [8] with modifications introduced
to maximise the suppression of MT growth without destroying the
mitotic spindle, which would have prevented the identification of
mitotic stages in drug-treated cells. Confluent NRK-52E cells were
incubated with culture medium containing nocodazole at a
concentration of 25 mg/ml for five min on ice. The cells were then
immediately fixed and immunostained as described below.
siRNA transfection of HeLa cells
HeLa cells were collected and resuspended in penicillin- and
streptomycin-free growth medium and seeded into 6-well dishes
(Costar), 1.6610
5 cells per well, for culture at 37uC, 5%CO2/95%
air for 20–24 h. ON-TARGETplus SMARTpool siRNA oligo-
nucleotides (Dharmacon) (sequences in table 2) were reconstituted
in RNAse-free water (Ambion) to make 2 mM siRNA solution.
This was mixed with DMEM and 2 ml DharmaFECT1 transfec-
tion reagent per well (Dharmacon) before dilution in penicillin-
and streptomycin-free growth medium, according to the manu-
facturer’s instructions, to make the siRNA transfection medium.
Antibiotic-free growth medium was removed from the cultured
HeLa cells and siRNA transfection medium was added prior to
48–72 h incubation at 37uC, 5%CO2/95% air.
Microinjection
On the day of microinjection, the mAbs or EB1-C84 GST fusion
protein and GST-protein only were prepared by adding Alexa 594-
conjugated dextran to the antibody solution. They were then
centrifuged at 4uC for 30 min at 13000 rpm and kept on ice until
used. The medium was removed from the confluent NRK-52E cell
cultures and replaced with CO2-independent medium (Gibco)
supplemented with glutamine and 10% foetal calf serum. The cells
were then transferred to the enclosed heated stage of a Zeiss
Axiovert inverted microscopeand allowedtoequilibrate for15 min.
Phase contrast imaging was used to identify prophase cells and cells
that showed no sign of nuclear envelope breakdown (NEB) were
chosen for microinjection. Needles (Eppendorf FemtoTips I) were
loaded with 3 ml of antibody solution and microinjection was
performed manually using an Eppendorf InjectMan NI 2 and
Eppendorf FemtoJet System. Injected cells were checked by
fluorescence microscopy to confirm a successful injection. Micro-
injected cells were then examined by phase contrast time lapse
imaging essentially as described previously [71]. Typically, images
were obtained using 161 binning and exposure times of less than
250 ms/frame with a time-lapse interval of 30 s, for up to 2 h. All
analyses were performed on original datasets composed of multi-
image TIFF files. For presentation as movies, image series were
saved as uncompressed AVI files then cropped, compressed and
converted into QuickTime movies using Adobe ImageReady 7.
Immunostaining
Cells were cultured on sterile coverglasses, processed for
immunocytochemistry using cold methanol fixation as described
previously [8] and imaged by fluorescence microscopy using a
Zeiss Axiovert 200 inverted microscope coupled to an Orca II ER
CCD camera (in conjunction with excitation/emission filtersets for
DAPI, FITC and TRITC) controlled by AQM6 software (Kinetic
Imaging, Nottingham, UK). Figures were assembled using Adobe
Photoshop 7.
Determination of metaphase plate thickness
Movies of injected cells were examined and anaphase onset
identified. The last frame prior to anaphase onset was then selected.
Two parallel lines were drawn on either side of the metaphase plate in
this frame using Andor IQ image analysis software. Each line
contacted the points furthest from the centre of the plate. The distance
between these two lines was then measured. The mean value for the
data for all analysed cells was calculated and plotted as a bar chart.
Determination of spindle alignment and placement
For determination of metaphase spindle positioning the still
images of metaphase cells obtained for metaphase plate thickness
Table 2. Sequence data for siRNA transfection.
Name
siRNA Oligonucleotide
Sequences (59-39) Target
GGAAAGCUACGGAACAUUG
ON-TARGETplus AAACGACCCUGUAUUGCAG EB1
SMARTpool MAPRE1 UGACAAAGAUCGAACAGUU
AGAUGAAGGCUUUGUGAUA
GAACAGGUACAUUCAUUAA
ON-TARGETplus GAAUGGCGGUCAAUGUGUA EB2
SMARTpool MAPRE2 GAACGUUGAUAAGGUAAUU
GGAGUAUGAUCCUGUAGAG
CCUCAACUAUACCAAGAUA
ON-TARGETplus CAGCAAACUUCGUGACAUC EB3
SMARTpool MAPRE3 GUAGAGAAAUUAGUGAAAG
UGAGACUGAUGCCCAAAUU
Table 2 summarises the sequences for the ON-TARGETplusSMARTpool siRNA
oligonucleotides used in the si RNA transfection.
doi:10.1371/journal.pone.0028884.t002
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movies were examined until the first sign of cleavage furrow
formation was seen. The frame prior to this was used for analysis.
For determination of spindle alignment the longitudinal axis,
drawn through the geometrical centre of the cell, was determined
and outlined on the still image. The axis of the spindle, drawn
through both spindle poles, was marked as a second line. The
angle between the cell axis and spindle axis was determined and
values above 20u were considered to be misaligned [65,66]. For
determination of metaphase spindle placement the geometric
centre of the cell was determined. The central point of the
metaphase plate was then defined and its distance from the cell
centre measured. The mean value was determined for the values
obtained for all the cells examined and plotted as a bar graph. We
found that spindle placement could only be meaningfully
examined in metaphase cells since anaphase spindle elongation
forced essentially all spindles into a central position.
Determination of anaphase spindle pole movement
Movies of injected cells were examined from the end of
metaphase until telophase onset using Andor IQ Tracker software
to follow the position of the centre-most point in each set of
segregating chromosomes as a proxy for the position of the spindle
poles, the positions of which were found to be difficult to
unambiguously determine in phase contrast images. The values
obtained for overall pole movement therefore also include a
component derived from chromosomal separation in anaphase A,
which appeared to occur normally in injected cells. Velocity values
for pole movement were then determined. To reveal any
asymmetries in spindle pole movement a ratio of the two velocity
values was calculated. If the velocity of spindle pole movement was
the same for both poles the ratio should be close to 1 for normal
pole movement, whereas uneven pole movement would be
highlighted by a value less than 1 with more severe cases nearing
0. The results were expressed as ratio values rather than actual
traces of individual cells to highlight those cells with severe spindle
pole movement.
Analysis of fluorescence intensities
The fluorescence intensities of microtubule staining in daughter
cells derived from microinjected mothers was determined as
follows. First, cell areas were determined using the outline of the
dextran fluorescence in the daughter cells as a guide. The total
amount of tubulin fluorescence in each daughter cell was then
determined using the Andor IQ software to obtain an integrated
intensity value. This was divided by the area value to allow
comparison of microtubule content in the two daughter cells.
The intensity of EB1 staining at spindle poles was determined
by identifying the location of the poles using centrin immuno-
staining and then measuring EB1 fluorescence intensity at the
poles using the Andor IQ software as described above.
SDS-PAGE and Western blotting
Cells from confluent 25 cm
2 flasks were extracted in lysis buffer
(PBS, 1% (v/v) Triton X- 100), containing EDTA free complete
protease inhibitor mix (Sigma) and phosphatase inhibitor cocktail
II (Sigma). After centrifugation, samples of supernatant were
mixed with NuPage
TM sample reducing agent, heated to 70uC for
10 min then separated by SDS-PAGE using a 10% Bis-Tris gel
and NuPage
TM gel system (Invitrogen). Proteins were transferred
onto nitrocellulose membranes using NuPage
TM transfer buffer
(Invitrogen) and probed with the 1A11 antibody as previously
described [47].
Statistical analysis
For statistical analysis, Chi-square tests and student t-tests were
performed using Microsoft Excel Software. A p-value of ,0.05
was considered statistically significant. Dr David Cairns (Leeds
University) gave invaluable statistical advice.
Supporting Information
Figure S1 Specificity of EB1 antibody 1A11 demonstrat-
ed in a full length Western blot. In addition to the full length
Western profile of the original blot (A) another Western was
carried out to confirm binding patterns (B). NRK-52E cells were
lysed and prepared in sample buffer as previously described.
Lysates were run on a 4–12% SDS-PAGE gel (Invitrogen) and
proteins were transferred to a PVDF membrane. The membrane
was blocked with 5% skimmed milk powder (Marvel) in PBS for
2 h on a rocker and incubated with the EB1 antibody 1A11 (1/
100) in 1% Marvel-PBS overnight at 4uC. The membrane was
washed 5 times for 5 min with PBS and then incubated with goat
anti-mouse antibody (1/10000) (Pierce) for 1 h at 21uC. After 5
further washes Pierce Femto Kit reagents were added to the
membrane and allowed to react for 5 min. Arrow indicates the
endogenous EB1 protein in the whole lysate. Endogenous EB1 is
present in NRK52-E cells as is recognized as an approx 30 kDa
protein in the full length Western blot by the EB1 antibody. We
also noted one additional band at around 55 kDa in the blot. 1A11
has been commercially available for some time and Western blot
images in for example the product sheet supplied by Cell Signaling
Technology (EB-1 1A11/4, cat. number 2164) appear to reveal
some additional non specific bands). Furthermore, an accessory
band at around 55 kDa has been shown in at least two other EB1
antibodies, for example abcam MAPRE1 antibody, ab50188, and
Novus Biological antibody NBP1 28753.
(TIF)
Figure S2 Diagram of the EB1 protein indicating
putative domains and binding sites for EB1 interactants
including APC (red), p150Glued (blue), MCAK (orange)
and CLIP-170 (purple). The antibody symbol indicates the
location of the region for the epitope recognised by 1A11. The
CLIP-170 binding region encompasses aa 125–168. The C-
terminal tyrosine is essential. MCAK binds within the last 84 aa of
EB1. The last 27 aa are essential.
(TIF)
Figure S3 Microinjection of two antibodies, 1A11 and
ALI 12–28, does not lead to an additive negative effect on
mitotic NRK-52E cells. Mitotic NRK-52E cells (n=17) were
microinjected as described under Materials and Methods with an
antibody mixture containing EB1 antibody 1A11 and APC
antibody ALI 12–28 at a needle concentration of 1 mg/ml each.
Microinjected cells were imaged and analysed as before. A. The
majority of microinjected cells complete mitosis. B. Microinjection
of a combination of both antibodies leads to a delay in cytokinesis
but not at other time points during mitosis. C. Early mitotic cortical
blebbing is reduced after co-injection of 1A11 and ALI 12–28. D.
Late mitotic cortical blebbing remains at high levels after co-
injection of 1A11 and ALI 12–28. E. The majority of the cells were
correctly aligned at TP1 and had all aligned correctly by TP 2. F.
Severe uneven spindle pole movement was observed in 25% of the
cells microinjected with a combination of 1A11 and ALI 12–28 (1-
1A11; 2- ALI-12-28; 3- 1A11 and 12–28 combined).
(TIF)
Table S1 Summary of blebbing in mitotic NRK-52E
cells microinjected with 1A11, ALI 12–28, C-APC 9.9 and
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cells microinjected with 1A11 whereas blebbing was observed
from prophase or prometaphase onwards in cells microinjected
with the APC antibodies.
(DOC)
Movie S1 Video of a mitotic NRK-52E cell microinjected
during prophase with the control antibody 4 U. Note the
tight chromosomal congression at the metaphase plate, the
absence of cortical blebbing and the smooth, symmetrical
chromosomal separation during anaphase. Images were obtained
using 161 binning and exposure times of less than 250 ms/frame
with a time-lapse interval of 30 s. For presentation as movies,
image series were saved as uncompressed AVI files then cropped,
compressed and converted into QuickTime movies using Adobe
ImageReady 7. Stills from this movie are presented in Figure 3A.
(MOV)
Movie S2 Video of mitotic NRK-52E cell microinjected
with the EB1-specific antibody 1A11. Note the comparative
looseness of chromosomal congression before anaphase onset, the
asymmetric movement of the separating chromosomes and the
cortical blebbing during anaphase. Images were obtained using
161 binning and exposure times of less than 250 ms/frame with a
time-lapse interval of 30 s, for up to 2 h. For presentation as
movies, image series were saved as uncompressed AVI files then
cropped, compressed and converted into QuickTime movies using
Adobe ImageReady 7. Stills from this movie are presented in
Figure 3B.
(MOV)
Movie S3 Video of mitotic NRK-52E cell microinjected
with the APC-specific antibody ALI 12–28. Note the
comparative looseness of chromosomal congression before ana-
phase onset. Images were obtained using 161 binning and
exposure times of less than 250 ms/frame with a time-lapse
interval of 30 s, for up to 2 h. For presentation as movies, image
series were saved as uncompressed AVI files then cropped,
compressed and converted into QuickTime movies using Adobe
ImageReady 7. Stills of this movie are presented in Figure 3C.
(MOV)
Movie S4 Video of mitotic NRK-52E cell microinjected
with the APC-specific antibody C-APC 9.9. Note the
cortical blebbing initiated during metaphase and the comparative
looseness of chromosomal congression before anaphase onset.
Images were obtained using 161 binning and exposure times of
less than 250 ms/frame with a time-lapse interval of 30 s, for up to
2 h. For presentation as movies, image series were saved as
uncompressed AVI files then cropped, compressed and converted
into QuickTime movies using Adobe ImageReady 7. Stills of this
movie are presented in Figure 3D.
(MOV)
Movie S5 Video of mitotic NRK-52E cell microinjected
with the APC-specific antibody C-APC 28.9. Note the
cortical blebbing initiated during metaphase and the comparative
looseness of chromosomal congression before anaphase onset.
Images were obtained using 161 binning and exposure times of
less than 250 ms/frame with a time-lapse interval of 30 s, for up to
2 h. For presentation as movies, image series were saved as
uncompressed AVI files then cropped, compressed and converted
into QuickTime movies using Adobe ImageReady 7. Stills of this
movie are presented in Figure 3E.
(MOV)
Movie S6 Video of mitotic NRK-52E cell microinjected
with the EB1-specific antibody 1A11. Note spindle misalign-
ment and misplacement at metaphase that is corrected by spindle
movements during anaphase. Images were obtained using 161
binning and exposure times of less than 250 ms/frame with a
time-lapse interval of 30 s, for up to 2 h. For presentation as
movies, image series were saved as uncompressed AVI files then
cropped, compressed and converted into Quicktime movies using
Adobe ImageRead 7. Stills of this movie are presented in
Figure 5C.
(MOV)
Movie S7 Video of a mitotic NRK-52E cell microinjected
during prophase with the control GST protein only. Note
the tight chromosomal congression at the metaphase plate, the
absence of cortical blebbing and the smooth, symmetrical
chromosomal separation during anaphase. Images were obtained
using 161 binning and exposure times of less than 250 ms/frame
with a time-lapse interval of 30 s. For presentation as movies,
image series were saved as uncompressed AVI files then cropped,
compressed and converted into QuickTime movies using Adobe
ImageReady 7. Stills from this movie are presented in Figure 12.
(MOV)
Movie S8 Video of a mitotic NRK-52E cell microinjected
during prophase with the EB1-C84 GST fusion protein.
Note the diffuse chromosomal congression at the metaphase plate,
cortical blebbing and the asymmetrical chromosomal separation
during anaphase and onwards. Also note the formation of an
ectopic cleavage furrow. Images were obtained using 161 binning
and exposure times of less than 250 ms/frame with a time-lapse
interval of 30 s. For presentation as movies, image series were
saved as uncompressed AVI files then cropped, compressed and
converted into QuickTime movies using Adobe ImageReady 7.
Stills from this movie are presented in Figure 12.
(MOV)
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